Pancreatic Acinar Cell Carcinoma

subtype

Identifier: CI-CAN-00006280
Entity page: /cancer/pancreatic-acinar-cell-carcinoma ↗
Edges: 60

Neighbours: 1 genes1 variants16 drugs10 trials
Drawn: 28 of 28 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Pancreatic Acinar Cell Carcinoma predicts response to …PREDICTS_RESPONSE_TO1 of 1
in context · predicts response to	ALK Fusionfusion → predicts response to Alectinib	sensitivity	C	Pancreatic Acinar Cell Carcinoma	1	Curated	civic	graph →
Pancreatic Acinar Cell Carcinoma associated with …

Pancreatic Acinar Cell Carcinoma investigated for …INVESTIGATED_FOR1 of 1
← investigated for	Alectinibsmall_molecule	supports	C	Pancreatic Acinar Cell Carcinoma	1	Curated	civic	graph →

Pancreatic Acinar Cell Carcinoma investigated for …INVESTIGATED_FOR1 of 1

← investigated for

Alectinibsmall_molecule

supports

Pancreatic Acinar Cell Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 29show all (up to 200)
→ investigated in trials for	Gemcitabinesmall molecule 8 trials (2 active) · roll-up of the cancer and its descendants	—	—	Pancreatic Acinar Cell Carcinoma	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Fluorouracilsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants	—	—	Pancreatic Acinar Cell Carcinoma	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Oxaliplatinsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants	—	—	Pancreatic Acinar Cell Carcinoma	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Leucovorinsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants	—	—	Pancreatic Acinar Cell Carcinoma	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Irinotecansmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants	—	—	Pancreatic Acinar Cell Carcinoma	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Carboplatinsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Pancreatic Acinar Cell Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Metforminsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Pancreatic Acinar Cell Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Nab-paclitaxel 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Pancreatic Acinar Cell Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Olaparibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Pancreatic Acinar Cell Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Paclitaxelsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Pancreatic Acinar Cell Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Vismodegibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Pancreatic Acinar Cell Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Akt Inhibitor MK2206 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Pancreatic Acinar Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Alisertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Pancreatic Acinar Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Bortezomibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Pancreatic Acinar Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Capecitabinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Pancreatic Acinar Cell Carcinoma	1	Observed	clinicaltrials	graph →

Pancreatic Acinar Cell Carcinoma studied in …STUDIED_INderived10 of 28show all (up to 200)
→ studied in	NCT04858334Phase 2 · recruiting APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation · condition mapped ONTOLOGY_EXACT · 28 trials mapped (6 active)	—	—	Pancreatic Acinar Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00878163Phase 1 · active not recruiting GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 28 trials mapped (6 active)	—	—	Pancreatic Acinar Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05286827Phase 2 · terminated Olaparib in Subjects With Advanced Pancreatic Acinar Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 28 trials mapped (6 active)	—	—	Pancreatic Acinar Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 28 trials mapped (6 active)	—	—	Pancreatic Acinar Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00669734Phase 1 · active not recruiting Vaccine Therapy and Sargramostim in Treating Patients With Pancreas Cancer That Cannot Be Removed By Surgery · condition mapped ONTOLOGY_EXACT · 28 trials mapped (6 active)	—	—	Pancreatic Acinar Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02047474Phase 2 · completed Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer · condition mapped ALIAS · 28 trials mapped (6 active)	—	—	Pancreatic Acinar Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04150042Phase 1 · recruiting SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells · condition mapped ONTOLOGY_EXACT · 28 trials mapped (6 active)	—	—	Pancreatic Acinar Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06115499Phase 2/Phase 3 · active not recruiting The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 28 trials mapped (6 active)	—	—	Pancreatic Acinar Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01821612early Phase 1 · completed Chemotherapy and Radiation Therapy Before Surgery Followed by Gemcitabine in Treating Patients with Pancreatic Cancer · condition mapped ALIAS · 28 trials mapped (6 active)	—	—	Pancreatic Acinar Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02178436Phase 1/Phase 2 · completed Gemcitabine, Nab-paclitaxel and KPT-330 in Advanced Pancreatic Cancer · condition mapped ALIAS · 28 trials mapped (6 active)	—	—	Pancreatic Acinar Cell Carcinoma	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains